FDA Clears First Breath-Actuated Dry-Powder SABA Inhaler FDA Clears First Breath-Actuated Dry-Powder SABA Inhaler

Teva's ProAir RespiClick (albuterol sulfate) is approved for treatment or prevention of bronchospasm with reversible obstructive airway disease and for prevention of exercise-induced bronchospasm. FDA Approvals
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Pulmonary Medicine News Alert Source Type: news